Gut microbiota: a potential new territory for drug targeting
Related Experiment Video
Updated: Jul 7, 2026

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
Published on: August 30, 2016
Wei Jia1, Houkai Li, Liping Zhao
1School of Pharmacy and at the Institute for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, People's Republic of China. weijia@sjtu.edu.cn.
Abstract:
The significant involvement of the gut microbiota in human health and disease suggests that manipulation of commensal microbial composition through combinations of antibiotics, probiotics and prebiotics could be a novel therapeutic approach. A systems perspective is needed to help understand the complex host-bacteria interactions and their association with pathophysiological phenotypes so that alterations in the composition of the gut microbiota in disease states can be reversed. In this article, we describe the therapeutic rationale and potential for targeting the gut microbiota, and discuss strategies and systems-oriented technologies for achieving this goal.
Related Concept Videos
Microbiota Modulation by Antibiotics
Functions of the Gut Microbiota
Microbiota of the Large Intestine
Introduction to the Human Microbiota
Dysbiosis of the Gut Microbiota
Microbiota of the Stomach and Small Intestine

